Earnings · China A-shares
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (002399) earnings
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit -28.84% year on year, -56.24% excluding one-off items. Wave Radar's earnings-quality score is 90 of 100 (Sound). The stock moved +2.53% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -28.84%
- Excl. one-offs YoY
- -56.24%
- Net profit QoQ
- +35.23%
- Result
- Bad / loss
- Quality score
- 90
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.54% | — |
| 3 days | +2.53% | — |
| 7 days | +2.64% | — |
| 14 days | -0.22% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +0.19%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥393.90M | -28.84% | -56.24% | -9.48% | 0.27 | 3.27% | +2.53% | — | — |
| 2026 interim report | 2026-08-29 | ¥275.28M | -34.74% | -62.01% | -8.44% | 0.19 | 2.28% | -4.59% | -10.72% | -1.38% |
| 2026 Q1 report | 2026-04-30 | ¥187.57M | +19.79% | -62.15% | -4.55% | 0.13 | 1.55% | +0.46% | -14.58% | -16.63% |
| 2025 annual report | 2026-03-31 | ¥349.49M | -45.96% | +66.11% | +3.75% | 0.24 | 2.88% | +3.82% | -8.09% | -16.51% |
| 2025 Q3 report | 2025-10-31 | ¥553.58M | -29.04% | +28.69% | +3.09% | 0.38 | 4.51% | +2.62% | -0.34% | +4.35% |
| 2025 interim report | 2025-08-30 | ¥421.85M | -36.44% | +29.34% | -0.71% | 0.29 | 3.41% | -1.09% | -9.38% | -10.22% |
| 2025 Q1 report | 2025-04-25 | ¥156.59M | +1.00% | +20.27% | +1.53% | 0.11 | 1.28% | -2.33% | +10.05% | +6.81% |
| 2024 annual report | 2025-03-29 | ¥646.74M | +182.57% | +132.51% | -3.03% | 0.44 | 5.39% | +0.09% | -3.46% | -1.91% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.